Chemical Component Summary

Name FLAVIN-ADENINE DINUCLEOTIDE
Identifiers [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl [[(2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxo-benzo[g]pteridin-10-yl)-2,3,4-trihydroxy-pentoxy]-hydroxy-phosphoryl] hydrogen phosphate
Formula C27 H33 N9 O15 P2
Molecular Weight 785.55  g/mol
Type NON-POLYMER
Isomeric SMILES Cc1cc2nc3c(nc(=O)[nH]c3=O)n(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n3cnc4c(N)ncnc34)c2cc1C
InChI InChI=1S/C27H33N9O15P2/c1-10-3-12-13(4-11(10)2)35(24-18(32-12)25(42)34-27(43)33-24)5-14(37)19(39)15(38)6-48-52(44,45)51-53(46,47)49-7-16-20(40)21(41)26(50-16)36-9-31-17-22(28)29-8-30-23(17)36/h3-4,8-9,14-16,19-21,26,37-41H,5-7H2,1-2H3,(H,44,45)(H,46,47)(H2,28,29,30)(H,34,42,43)/t14-,15+,16+,19-,20+,21+,26+/m0/s1
InChIKey VWWQXMAJTJZDQX-UYBVJOGSSA-N

Chemical Details

Formal Charge 0
Atom Count 86
Chiral Atom Count 9
Chiral Atoms C1B C2' C2B C3' C3B C4' C4B P PA
Bond Count 91
Aromatic Bond Count 16
Leaving Atoms n/a

Drug Info: DrugBank

DrugBank ID DB03147   (Stereoisomeric match)
Name Flavin adenine dinucleotide
Groups approved
Description A condensation product of riboflavin and adenosine diphosphate. The coenzyme of various aerobic dehydrogenases, e.g., D-amino acid oxidase and L-amino acid oxidase. (Lehninger, Principles of Biochemistry, 1982, p972) Flavin adenine dinucleotide is approved for use in Japan under the trade name Adeflavin as an ophthalmic treatment for vitamin B2 deficiency.
Synonyms
  • Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine
  • Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]
  • FAD
  • Flavin adenine dinucleotide
  • FLAVIN-adenine dinucleotide
Salts
  • Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine
  • Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]
  • FAD
  • Flavin adenine dinucleotide
  • FLAVIN-adenine dinucleotide
Brand Names
  • Adeflavin
  • Flaziren
Affected Organism Humans and other mammals
Indication Used to treat eye diseases caused by vitamin B2 deficiency, such as keratitis and blepharitis.
CAS number 146-14-5

Drug Targets

Name Sequence Search Pharmacological Action Actions
Sulfite reductase [NADPH] flavoprotein alpha-component MTTQVPPSALLPLNPEQLARLQAATTDLTPTQLAWVSGYFWGVLNQQPAA... unknown
5,10-methylenetetrahydrofolate reductase MSFFHASQRDALNQSLAEVQGQINVSFEFFPPRTSEMEQTLWNSIDRLSS... unknown
NADPH:adrenodoxin oxidoreductase, mitochondrial MASRCWRWWGWSAWPRTRLPPAGSTPSFCHHFSTQEKTPQICVVGSGPAG... unknown
Glutathione reductase MTKHYDYIAIGGGSGGIASINRAAMYGQKCALIEAKELGGTCVNVGCVPK... unknown
Amine oxidase [flavin-containing] B MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQK... unknown
View More Drug Targets
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID: 21059682